Objective-Although stromal cell-derived factor (SDF)-1α is well known to modulate the mobilization of hematopoietic stem cells and endothelial progenitor cells, its effects on some pre-existing vascular functions remain unknown. We have investigated here the role of SDF-1α signaling in endothelial barrier function. Approach and Results-Treatment with SDF-1α elevated transendothelial electrical resistance and inhibited the dextran hyperpermeability elicited by thrombin in bovine aortic endothelial cells, both indicating an increase in endothelial barrier function. SDF-1α binds to 2 receptors, C-X-C chemokine receptor types 4 and 7 (CXCR4 and CXCR7). Pretreatment with a CXCR4 antagonist or CXCR4 gene depletion by small interfering RNA (siRNA) eliminated SDF-1α-induced endothelial barrier enhancement. In contrast, CXCR7 antagonist or CXCR7 gene depletion by siRNA did not influence SDF-1α-induced barrier enhancement. Pretreatment with a Gi-protein inhibitor, a phosphoinositide 3-kinase (PI3K) inhibitor, or PI3K p110γ subunit gene depletion by siRNA also inhibited SDF-1α-induced barrier enhancement significantly. Western blot analysis revealed that SDF-1α phosphorylated Akt Ser473 in endothelial cells, suggesting PI3K activation. Immunostaining showed that treatment with SDF-1α formed a cortical actin rim, which was accompanied by Rac1 activation. In vivo, SDF-1α inhibited croton oil-induced vascular leakage indexed by dye extravasation, which is attenuated by a pretreatment with a CXCR4 antagonist. ). These cellular responses cause cytoskeletal rearrangement and adherens junction disassembly leading to barrier disruption.
Conclusions-We9 Vascular endothelial growth factor stimulates receptor tyrosine kinase to produce NO, which disrupts cell-cell adhesion and increases barrier permeability. 10 In contrast, S1P is well known to enhance EC adhesion and barrier formation strongly via activation of its Gi protein-coupled receptor and its downstream signaling molecules, phosphoinositide 3-kinase (PI3K) and Rac1 GTPase.9,11 Because of their adhesion-promoting properties, these barrier regulatory molecules can be considered possible therapeutic targets against various types of inflammatory diseases. 8,12,13 The discovery of a novel vascular barrier modulator and the elucidation of its mechanism of action could also provide new opportunities for the treatment of inflammatory diseases.In the present study, we have attempted to elucidate whether and how SDF-1α modulates vascular endothelial permeability. We have found that the SDF-1α/CXCR4 axis promotes barrier enhancement in vascular ECs.
Materials and MethodsMaterials and Methods are available in the online-only Supplement.
Results
SDF-1α Promotes Endothelial Barrier IntegrityAs shown in Figure 1A and 1B, SDF-1α (1-100 ng/mL) dose dependently increased transendothelial electrical resistance (TER) in bovine aortic ECs (BAECs), indicating endothelial barrier enhancement. TER reached a peak 10 minutes after SDF-1α stimulation and returned to a basal level within 75 minutes. T...